sellWeak10b5-1 plan
Randall Kaye sold $984k of LBPH
CMO at Longboard Pharmaceuticals, Inc.. 16,667 shares at an average of $59.04, traded Oct 15, 2024, filed Oct 16, 2024.
Warning score
15Value
$984k
16,667 shares
Holdings after
17,920
-48% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- +25Trade size$984k at market
- +10Share of holdings soldSold 48% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-24-115026, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 15, 2024 | MOption exercise Common Stock10b5-1 | +16,667 | $4.35 | $73k | 34,587 | Oct 16, 2024 |
| Oct 15, 2024 | SOpen-market sale Common Stock10b5-1 | -16,667 | $59.04 | $984k | 17,920 | Oct 16, 2024 |
| Oct 15, 2024 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -16,667 | $0.00 | $0 | 96,300 | Oct 16, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.